Repeat customers are now the ones asking for more capacity: management describes buyers it has already served pressing f
The model's full reasoning — Q2 2018 call → NOThe question asks whether management describes a situation where proven, repeat counterparties are asking for more than the company can currently supply, and the company is enlarging itself in response. Let me search the transcript for relevant evidence. Key elements needed: 1. Pressure from proven, repeat counterparties (existing customers/partners who have already transacted and want more) 2. The ask exceeds what the company can currently supply 3. The company is enlarging itself now, with numbers not yet showing it Let me scan the transcript for any such description. The transcript covers: - Q2 2018 earnings call for Fresenius Medical Care - Topics: Calcimimetics transition, Sound divestment, Care Coordination margins, ESRD payment rule, ESCOs, Patients Act, MSP extension, China investments, PD products Looking for evidence of existing customers asking for more than the company can supply... The China discussion: "we're putting production capability in for PD. We have been servicing the PD market in Asia Pacific out of EMEA and obviously that gives us some transaction concern. So to put it in country, we think it makes sense so there's some investment that will come into there and as you all know when you put production capacity in a factory you got to have volume and you got to give really get ramping in order to get your most ideal cost and so we try to give you a heads-up, that will some impact as we go through the next quarters." This is about putting production in China for PD products, but it doesn't describe existing customers asking for more than the company can supply. It's about cost optimization and local content requirements. The PD product discussion: "we have a Salencia cycler... the JV with Debiotech is still underway... on the sorbent side... We have good confidence in our cartridge. It's working really well. We're less happy with what we see on the hardware side, but we're working on that." This is about product development, not about existing customers demanding more than supply. The ESCO discussion: "we're sitting in a place today where we're roughly at about 41,000 patients in the ESCOs which we've been there for most of the quarter.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ROCK | Gibraltar Industries, Inc. | Q1 2024 | 2024-05-01 | B+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| FSS | Federal Signal Corporation | Q1 2018 | 2018-05-12 | A |
ROCK · Q1 2024 → YESThe question is whether management describes that buyers who have already bought from the company and seen the result are now asking for more than the company can currently supply, and management is w...YES The transcript shows management describing exactly this situation in the renewables segment. Existing customers who previously bought fixed-tilt racking (proven repeat counterparties) have switched to the new 1P TerraTrak tracker technology, creating rapid uptake that exceeds current supply capability.
GIII · Q4 2024 → YESThe question is whether management describes that buyers who have already bought from the company and seen the result are now asking for more than the company can currently supply, and management is w...
PI · Q4 2022 → YESThe question is whether management describes that buyers who have already bought from the company and seen the result are now asking for more than the company can currently supply, and management is w...